Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum tumour associated trypsin inhibitor, as a biomarker for survival in renal cell carcinoma

Published:2020-08-04 Issue:5 Volume:54 Page:413-419
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Tornberg Sara V.¹,Nisen Harry¹,Järvinen Petrus¹^ORCID,Järvinen Riikka¹,Kilpeläinen Tuomas P.¹,Taari Kimmo¹,Stenman Ulf-Håkan²,Visapää Harri¹³

Affiliation:

1. Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

2. Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

3. Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2020.1798501

Reference31 articles.

1. Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)

2. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

3. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

4. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

5. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of SPINK1 and SPINK1‐based diagnostic model in detection of hepatocellular carcinoma;Journal of Clinical Laboratory Analysis;2021-09-27

2. Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status;Cancers;2021-06-04

3. Prognostic and predictive biomarkers for metastatic renal cell carcinoma;Journal of Cancer Metastasis and Treatment;2021

4. Genomic Fabric Remodeling in Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): A New Paradigm and Proposal for a Personalized Gene Therapy Approach;Cancers;2020-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3